Core Viewpoint - Hunan Juren New Materials Co., Ltd. has received approval for its IPO on the Beijing Stock Exchange, focusing on the research, production, and sales of caprolactam series products, positioning itself as an innovative manufacturer in advanced chemical materials [2]. Group 1: IPO Details - The company plans to raise 292 million yuan through the IPO, which will be allocated to a 40,000 tons per annum special polycaprolactone intelligent chemical plant project, a research and development center project, and to supplement working capital [3]. Group 2: Financial Performance - The company's revenue for the years 2022, 2023, and 2024 is reported as 192 million yuan, 282 million yuan, and 479 million yuan respectively, with net profits of 47.26 million yuan, 74.20 million yuan, and 83.35 million yuan for the same years [4]. - The total assets as of December 31, 2024, are projected to be approximately 781.77 million yuan, with total equity of about 687.41 million yuan, reflecting a significant increase from previous years [4]. Group 3: Shareholding Structure - The controlling shareholder of the company is Yueyang Juyi, holding 15.07 million shares, which accounts for 41.85% of the total shares, while the actual controller, Wang Hanyu, indirectly holds 56.61% of the voting rights through various holding platforms [6].